Evidence map›Paper›PMID 41346612›Full record

ArticleFrontiers in immunology2025

Splenectomy modulates intrarenal B cell differentiation and impairs repair of post-ischemic kidney.

Kyungho Lee, Hojin Jeon, Kyung Sub Lee, Junseok Jeon, Jung Eun Lee, Ghee Young Kwon, Wooseong Huh, Hye Ryoun Jang

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kyungho Lee *Division of Nephrology, Department of Medicine, Samsung Medical Center, Cell and Gene Therapy Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Hojin Jeon *Division of Nephrology, Department of Medicine, Samsung Medical Center, Cell and Gene Therapy Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kyung Sub LeeSamsung Advanced Institute for Health Sciences and Technology, Seoul, Republic of Korea.
Junseok JeonDivision of Nephrology, Department of Medicine, Samsung Medical Center, Cell and Gene Therapy Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Jung Eun LeeDivision of Nephrology, Department of Medicine, Samsung Medical Center, Cell and Gene Therapy Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ghee Young KwonDepartment of Pathology, Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Wooseong HuhDivision of Nephrology, Department of Medicine, Samsung Medical Center, Cell and Gene Therapy Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Hye Ryoun JangDivision of Nephrology, Department of Medicine, Samsung Medical Center, Cell and Gene Therapy Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lymphocytes are known to regulate kidney repair after ischemia-reperfusion injury (IRI). Splenectomy has been proposed as a preconditioning protocol for high-risk kidney transplantation and has been suggested to affect IRI outcomes. However, the role of splenectomy in IRI repair remains poorly understood. This study investigated the effects of splenectomy on the immunological microenvironment in a mouse model of kidney IRI. Methods: C57BL/6 mice underwent severe (45 min) unilateral (left) IRI and were divided into two groups: IRI surgery alone (IRI group) and IRI surgery with simultaneous splenectomy (IRI+SPX group). Post-ischemic and contralateral kidneys were collected on days 10 and 30 after IRI. Kidney function, histology, lymphocyte population (analyzed by flow cytometry), and cytokine/chemokine expression were evaluated. Results: The plasma creatinine levels were higher in the IRI+SPX group on day 10, while the cystatin C concentrations were not significantly different between the two groups. The percentage of tubular damage and fibrosis in post-ischemic kidneys during the repair phase was significantly higher in the IRI+SPX group than in the IRI group. While the T cell profiles were comparable between the groups, the proportions of activated B cells and MHCII+ B cells in the post-ischemic and contralateral kidneys were higher in the IRI+SPX group on day 30 after IRI. The expressions of IL-17, MCP-1, and TGF-β in post-ischemic kidneys were higher in the IRI+SPX group compared with the IRI group. Discussion: Splenectomy exacerbates tubular damage and fibrosis during the repair phase of severe IRI and significantly alters the immunological microenvironment of the kidneys, promoting B cell differentiation. Our study suggests that splenectomy may worsen outcomes in IRI, and further studies investigating potential reparative pathways through the kidney-spleen axis are warranted.

Indexed as

B-LymphocytesCell DifferentiationKidneyReperfusion InjurySplenectomyAcute Kidney InjuryAnimalsCytokinesDisease Models, AnimalMaleMiceMice, Inbred C57BLCytokinesacute kidney injuryB cellimmune cellsischemia-reperfusion injuryrepairspleensplenectomy

Identifiers

PMID41346612
PMCPMC12672880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.